Source: Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2013 Mar; Vol. 112 (3), pp. 209-14. Date of Electronic Publication: 2012 Dec 06.Publisher: Blackwell Country of Publication: England NLM ID: 101208422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-7843

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Optimization of warfarin dose by population-specific pharmacogenomic algorithm.

Authors : Pavani A; Department of Clinical Pharmacology and Therapeutics, Nizam's Institute of Medical Sciences, Hyderabad, India.; Naushad SM

Subjects: Anticoagulants/Anticoagulants/Anticoagulants/*administration & dosage ; Aryl Hydrocarbon Hydroxylases/Aryl Hydrocarbon Hydroxylases/Aryl Hydrocarbon Hydroxylases/*genetics ; Mixed Function Oxygenases/Mixed Function Oxygenases/Mixed Function Oxygenases/*genetics

Source: The pharmacogenomics journal [Pharmacogenomics J] 2012 Aug; Vol. 12 (4), pp. 306-11. Date of Electronic Publication: 2011 Mar 01.Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101083949 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose.

Authors : Takeuchi F; Wellcome Trust Sanger Institute, Hinxton, UK.; McGinnis R

Subjects: Genome-Wide Association Study* ; Polymorphism, Single Nucleotide*; Aryl Hydrocarbon Hydroxylases/Aryl Hydrocarbon Hydroxylases/Aryl Hydrocarbon Hydroxylases/*genetics

Source: PLoS genetics [PLoS Genet] 2009 Mar; Vol. 5 (3), pp. e1000433. Date of Electronic Publication: 2009 Mar 20.Publisher: Public Library of Science Country of Publication: United States NLM ID: 101239074 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Evaluation of genetic factors for warfarin dose prediction.

Authors : Caldwell MD; Center for Human Genetics, Marshfield Clinic Research Foundation, 1000 North Oak Avenue, Marshfield, WI 54449, USA.; Berg RL

Subjects: Anticoagulants/Anticoagulants/Anticoagulants/*therapeutic use ; Aryl Hydrocarbon Hydroxylases/Aryl Hydrocarbon Hydroxylases/Aryl Hydrocarbon Hydroxylases/*genetics ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*drug therapy

Source: Clinical medicine & research [Clin Med Res] 2007 Mar; Vol. 5 (1), pp. 8-16.Publisher: Marshfield Clinic Country of Publication: United States NLM ID: 101175887 Publication Model: Print Cited Medium: Print ISSN: 1539-4182

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients.

Authors : Mushiroda T; Laboratory for Pharmacogenetics, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN), Tokyo, Japan.; Ohnishi Y

Source: Journal of human genetics [J Hum Genet] 2006; Vol. 51 (3), pp. 249-253. Date of Electronic Publication: 2006 Jan 24.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 9808008 Publication Model: Print-Electronic Cited Medium: Print ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Common VKORC1 and GGCX polymorphisms associated with warfarin dose.

Authors : Wadelius M; Department of Medical Sciences, Clinical Pharmacology, University Hospital, Uppsala, Sweden. ; Chen LY

Subjects: Polymorphism, Single Nucleotide*; Anticoagulants/Anticoagulants/Anticoagulants/*administration & dosage ; Carbon-Carbon Ligases/Carbon-Carbon Ligases/Carbon-Carbon Ligases/*genetics

Source: The pharmacogenomics journal [Pharmacogenomics J] 2005; Vol. 5 (4), pp. 262-70.Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101083949 Publication Model: Print Cited Medium: Print ISSN: 1470-269X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Accuracy assessment of pharmacogenetic algorithms for warfarin dose prediction in Chinese patients

Authors : Yanhai Guo; Ping Liang; Zhen Yan

Subjects: Adult; Male; China

Source: American Journal of Hematology. 87:541-544

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Evaluation of pharmacogenetic algorithm for warfarin dose requirements in Japanese patients

Authors : Yuriko Tanaka; Toshitaka Kashima; Shigeru Hosaka

Subjects: Male; Low dosage; Alcohol Drinking

Source: Circulation journal : official journal of the Japanese Circulation Society. 74(5)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Pharmacogenetic Impact of VKORC1 and CYP2C9 Allelic Variants on Warfarin Dose Requirements in a Hispanic Population Isolate

Authors : Mauricio Camargo; Diana Falla; Ignacio Tobon

Subjects: Adult; Male; medicine.medical_specialty

Source: Clinical and Applied Thrombosis/Hemostasis. 16:83-90

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

CYP4F2 Is a Vitamin K1 Oxidase: An Explanation for Altered Warfarin Dose in Carriers of the V433M Variant

Authors : Clara K. Hsia; Mariko Nakano; Allan E. Rettie

Subjects: Vitamin; Heterozygote; Genotype

Source: Molecular Pharmacology. 75:1337-1346

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Impact of genetic factors (CYP2C9, VKORC1 and CYP4F2) on warfarin dose requirement in the Turkish population.

Optimization of warfarin dose by population-specific pharmacogenomic algorithm.

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose.

Evaluation of genetic factors for warfarin dose prediction.

Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients.

Common VKORC1 and GGCX polymorphisms associated with warfarin dose.

Accuracy assessment of pharmacogenetic algorithms for warfarin dose prediction in Chinese patients

Evaluation of pharmacogenetic algorithm for warfarin dose requirements in Japanese patients

Pharmacogenetic Impact of VKORC1 and CYP2C9 Allelic Variants on Warfarin Dose Requirements in a Hispanic Population Isolate

CYP4F2 Is a Vitamin K1 Oxidase: An Explanation for Altered Warfarin Dose in Carriers of the V433M Variant

اتصل بنا

اتبع